Neuroleptic malignant syndrome with use of quetiapine in mental retardation

Dan, Amitava; Bharadwaj, Rahul; Grover, Sandeep

doi:10.1111/j.1440-1819.2008.01921.x

Cited by 6 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Accurate and timely diagnosis of NMS is vital to ensure appropriate treatment in hospital is instigated to reduce the high risk of death. NMS is associated with FGA but there is a growing evidence of NMS following treatment with second-generation antipsychotics such as Quetiapine [22,23].…”

Section: Neuroleptic Malignant Syndromementioning

confidence: 99%

Oxford Textbook of the Psychiatry of Intellectual Disability

2020

View full text Add to dashboard Cite

Intellectual Disability (ID), a lifelong condition characterized by an impairment of intellectual functioning and deficits in adaptive skills is part of a spectrum of developmental disorders which also includes other conditions like autism and ADHD. While psychiatric problems are three to four times more common in those with ID, diagnosing it can be fraught with difficulties due to associated communication problems, atypical presentations, overlap with physical conditions, and experience of marginalization and abuse. In addition, treatment approaches may be different and the potential for treatment-related side effects greater. With a range of international experts authoring its chapters and providing the up-to-date evidence base in assessment, diagnosis, and treatment of mental health problems in people with ID, this book will be useful not just for the trainee doctor in psychiatry, but also for those in allied professions like general practice, nursing, psychology, speech and language therapy, social work, and occupational therapy as well as family members and carers and all those involved in any way with organizing or delivering care and treatment for people with intellectual disability and mental health problems. Throughout, the book addresses issues that are of relevance to those on the frontline and hence most chapters offer examples of clinical issues that come up in day to day practice. There are also a number of single response multiple choice questions that will serve as an aid to learning.

show abstract

Section: Neuroleptic Malignant Syndromementioning

confidence: 99%

Oxford Textbook of the Psychiatry of Intellectual Disability

2020

View full text Add to dashboard Cite

show abstract

Section: Neuroleptic Malignant Syndromementioning

confidence: 99%

Physical Health in People with Intellectual Disabilities

Chauhan¹,

Courtenay²,

Hoghton³

2020

Oxford Textbook of the Psychiatry of Intellectual Disability

View full text Add to dashboard Cite

The aim of this chapter is to outline the importance of good physical health for a person with intellectual disability (ID) on their mental health and wellbeing; the impact of the choice of psychotropic therapy on their physical health; the presentations of mental disorders in people with ID with health problems; what to include in assessment—good history taking, physical examination, and investigations. Other aspects covered are the management of health problems including health prevention and what to monitor; the role of guidelines; and importance of liaison with GPs and the Primary Care Team.

show abstract

“…8 As to adverse effects of treatments, Dan et al reported a case of severe mental retardation in a 20-year-old man who had a fatal outcome of neuroleptic malignant syndrome caused by quetiapine used to control his frequent unprovoked aggression. 9 Kato et al reported a case of schizophrenia in a 24-year-old woman in whom tardive dystonia developed after risperidone administration was improved by switching risperidone to aripiprazole. 10 Echizenya et al noted that adolescents with freerunning disorder (non-24-h sleep-wake syndrome) have a risk of developing a paradoxical reaction when they take hypnotics based on two such cases…”

Section: P Sychiatry and Clinical Neurosciencesmentioning

confidence: 99%

“…As to adverse effects of treatments, Dan et al . reported a case of severe mental retardation in a 20‐year‐old man who had a fatal outcome of neuroleptic malignant syndrome caused by quetiapine used to control his frequent unprovoked aggression 9 . Kato et al .…”

mentioning

confidence: 99%

Case Reports in Psychiatry and Clinical Neurosciences

Kitamura¹

2011

Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Neuroleptic malignant syndrome with use of quetiapine in mental retardation

Cited by 6 publications

References 14 publications

Oxford Textbook of the Psychiatry of Intellectual Disability

Oxford Textbook of the Psychiatry of Intellectual Disability

Physical Health in People with Intellectual Disabilities

Case Reports in Psychiatry and Clinical Neurosciences

Contact Info

Product

Resources

About